Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
COLIMYCIN
ID: ALA507048
Max Phase: Preclinical
Molecular Formula: C45H85N13O10
Molecular Weight: 968.26
Molecule Type: Protein
Associated Items:
ID: ALA507048
Max Phase: Preclinical
Molecular Formula: C45H85N13O10
Molecular Weight: 968.26
Molecule Type: Protein
Associated Items:
Synonyms (1): Colimycin
Synonyms from Alternative Forms(1):
Canonical SMILES: CCC(C)CCCCC(=O)NCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H]([C@@H](C)O)NC1=O
Standard InChI: InChI=1S/C45H85N13O10/c1-8-27(6)11-9-10-12-36(60)50-22-17-33-42(65)58-37(28(7)59)45(68)55-32(16-21-49)39(62)51-29(13-18-46)38(61)52-30(14-19-47)40(63)56-34(23-25(2)3)43(66)53-31(15-20-48)41(64)57-35(24-26(4)5)44(67)54-33/h25-35,37,59H,8-24,46-49H2,1-7H3,(H,50,60)(H,51,62)(H,52,61)(H,53,66)(H,54,67)(H,55,68)(H,56,63)(H,57,64)(H,58,65)/t27?,28-,29+,30+,31+,32+,33+,34+,35+,37+/m1/s1
Standard InChI Key: RPABDKTXMKOGKI-OYTUFZPASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 968.26 | Molecular Weight (Monoisotopic): 967.6542 | AlogP: -3.14 | #Rotatable Bonds: 22 |
Polar Surface Area: 386.21 | Molecular Species: BASE | HBA: 14 | HBD: 14 |
#RO5 Violations: 3 | HBA (Lipinski): 23 | HBD (Lipinski): 18 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.71 | CX Basic pKa: 10.15 | CX LogP: -4.85 | CX LogD: -13.23 |
Aromatic Rings: 0 | Heavy Atoms: 68 | QED Weighted: 0.05 | Np Likeness Score: 0.55 |
1. Daikos GL, Kosmidis C, Tassios PT, Petrikkos G, Vasilakopoulou A, Psychogiou M, Stefanou I, Avlami A, Katsilambros N.. (2007) Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome., 51 (7): [PMID:17452479] [10.1128/aac.00044-07] |
Source(1):